67 Infos zu Georg Lautscham

16 Aktuelle Nachrichten

Dr. Georg Lautscham Oktober 23, Über uns. Kontaktieren Sie uns: info@ goingpublic.de. Folgen Sie uns. MEDIADATEN GOING PUBLIC MAGAZIN ...

Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced...

Protagen CEO Georg Lautscham said: “Immunotherapies are a new cornerstone in treating cancer patients. An important challenge is to ...

Die neuesten Informationen aus Dillingen erhalten Sie rund um die Uhr bei Ihrer Saarbrücker Zeitung. Die SZ versorgt Sie mit den aktuellsten Meldungen.

2 Profile in Sozialen Netzwerken

Georg Lautschams berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Georg Lautscham …

größten beruflichen Netzwerk. 1 Job Job ist im Profil von Georg Lautscham aufgelistet. Sehen Sie sich auf LinkedIn das vollständige Profil an. Erfahren Sie mehr über die Kontakte von Georg Lautscham und über Jobs bei ähnlichen ...

2 Hobbys & Interessen

Dr. Georg Lautscham CBO Tel: +49 (0) Fax: +49 (0) or. Media Enquiries BioStrata

califax : CONGRESS DAY th April: FEDERAL AND GLOBAL IMMUNISATION FOCUS http://www.terrapinn.com wvcdc/programme.stm How outsourcing...

2 Business-Profile

Life Sciences Business Intelligence Web Portal for European countries

Life Sciences Business Intelligence Web Portal for Germany, Austria and Switzerland

2 Bücher zum Namen

Dr. Georg Lautscham is CEO at Protagen AG. He joined Protagen in 2013, as he felt that patients suffering from cancer and autoimmune diseases should receive

Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin- independent ...

2 Dokumente

Identification of a TAP-Independent, Immunoproteasome-Dependent CD8 + T- Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2 Georg Lautscham

Protagen AG, Dr. Georg Lautscham, CBO. 11:45 Company presentation. / CorTec GmbH, Dr. Jörn Rickert, CEO & Founder. Lunch Break.

2 Allgemeine Veröffentlichungen

Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2. By Georg Lautscham, ...

It is becoming increasingly apparent that the majority of tumours display defects in the MHC class I antigen processing pathway, particularly low levels of

2 Meinungen & Artikel

European Organisation for Research and Treatment of Cancer

27 Webfunde aus dem Netz

View Georg Lautscham's professional profile on LinkedIn. LinkedIn ... Join LinkedIn and access Georg Lautscham's full profile. It's free! ... Max Delbrueck Center.

Dr. Georg Lautscham CBO T + F + bd@ protagen.com or. Media Enquiries BioStrata. Dr. Clare Russell

A chemist and immunologist by training, he also has over 15 years of experience as a Biotech Executive, with a strong commercial track record in business...

Dr. Georg Lautscham, CBO Tel: +49 (0) Fax: +49 (0) or BioStrata. Dr. Clare Russell

Georg lautscham : Baby Name Georg lautscham Meaning,Pronunciation,Origin,Religion,Pronounce of Baby Name Georg lautscham. Similar Names ,All about the name...

Georg Lautscham hasn't made any photos public yet. About · Jobs · Blog · Developers · Guidelines · Report abuse · Help forum · English · Privacy · Terms · Help.

Meaning of baby name Georg lautscham in different languages

Die sicherste und umfassendste globale Gemeinschaft von Fotografie-Enthusiasten. Der beste Ort für Inspiration, Kontakt und Austausch!

By Dr. Georg Lautscham, chief business officer (CBO), and Dr. Stefan Müllner, CEO and cofounder, Protagen. Precision medicine (also known ...

42 INTERVIEW - PROTAGEN AG DAMIT THERAPIEN KÜNFTIG BESSER WIRKEN Dr. Georg Lautscham 43 Warum sprechen manche Patienten positiv auf  ...

Encorium Oy is a None company based in, Germany, which employs 1 people..

Contributors. Author: Georg Lautscham. Author: Tracey Haigh. Author: Sabine Mayrhofer. Author: Graham Taylor. Author: Debbie Croom-Carter.

Cancer is still one of the main causes of death worldwide, yet recent strides towards more effective treatments have been made in the form of new cancer...

Searchable database of Herpesviridae genomes with visualization and analysis tools.

NCI will use the SeroTag immune system profiling technology to identify biomarkers that can predict therapy response and adverse reactions.

As such, it is set to benefit any new SSc clinical development program,” added Georg Lautscham, Chief Business Officer at Protagen.

Farah Aladin, Georg Lautscham, Elizabeth Humphries, Judy Coulson, more · Cancer Immunology, Immunotherapy 56 , 8 ,

Protagen CBO Georg Lautscham commented: "Our innovative SeroTag technology has proven on numerous occasions that it can monitor the ...

Protagen Inc. Selected By Pfizer Inc. To Support Clinical Drug Development Of A Novel Compound In Autoimmune Diseases - read this article along with other...

With a series of recent collaborations in hand, the company is leveraging its experience in autoimmune biomarkers to move into the immunoncology space.